--- canonical_url: https://www.stockexpertai.com/earnings/pg last_updated: 2026-05-03T20:45:51.531Z --- # The Procter & Gamble Company (PG) Q1 FY2027 Earnings Preview > This content was automatically generated with FMP live data + Q2 FY2026 earnings call transcript. Generated: 2026-05-03T20:45:50.245Z. Educational tool, not investment advice. --- ## Quick Summary | Field | Value | Source | |---|---|---| | Price | $147.27 (▲ 0.12%) | fmp:quote | | Market Cap | $342.9B | fmp:profile | | 52w range | $137.62 – $170.99 | fmp:quote | | Earnings | Tue 4 Aug | fmp:earnings-history | | EPS estimate | $1.46 (-1% YoY) | fmp:earnings-estimate | | Revenue estimate | $21.4B | fmp:earnings-estimate | | Beat streak | 5/4 | fmp:earnings-history | | Rating | B+ (overall 3/5) | fmp:ratings | | Analyst median target | $164 (+11.0% upside) | fmp:price-target-consensus | | MoonshotScore | 44/100 | derived | | Council | 2/6 bullish | derived | | Munger verdict | Fairly Valued | derived | ## The Procter & Gamble Company — Q1 FY2027 Expectations Q1 consensus: revenue $21.4B^{[FMP est]}, EPS $1.46^{[FMP est]}. 5 consecutive quarters of beat^{[FMP earnings]}. ## Quick Take **Score:** B+ · **Stance:** HOLD · **Council:** 2/6 · **Moonshot:** 44 = MoonshotScore 44^{[9-pillar formula]} + Council 2/6^{[6-lens rule]}. Form 4: 0 transactions^{[FMP Form 4]}. ## Watchlist (4 metrics) ### 1. Fy26 Organic Sales Guidance PG continues to expect organic sales growth of in line to plus 4% for fiscal year 2026, which includes 30 to 50 basis points of headwind from product and market exits. > "For fiscal 'twenty-six, we continue to expect organic sales growth of in line to plus 4%. As a reminder, this guidance includes 30 to 50 basis points of headwind from product and market exits, that are part of our restructuring work." > — Andre Schulten, Expectation / Guide · Q2 FY2026 ### 2. Fy26 Guidance Maintained PG is maintaining fiscal year 2026 guidance ranges across organic sales, core EPS, and adjusted free cash flow productivity, despite softer consumer markets and competition. > "We expect stronger results in the second half which enables us to maintain fiscal year 2026 guidance ranges across organic sales core EPS and adjusted free cash flow productivity." > — Andre Schulten, Expectation / Guide · Q2 FY2026 ### 3. Downy Intense Perfume Innovation Downy Intense leverages perfume innovation and consumer insight, driving double-digit organic sales growth and over two points for value share growth in the Mexico fabric enhancer category. > "These deep consumer insights driving innovation and executed with shopper brand communication and retail execution as spurred Mexico fabric enhancer category growth, and led Downey to double-digit organic sales growth and over two points for value share growth." > — Shailesh Jejurikar, Investor Focus · Q2 FY2026 ### 4. Pampers Prestige Success Pampers Prestige has driven double-digit organic sales growth and increased share nearly three points in Greater China with its silky ingredients and luxurious packaging. > "Reframing our superior premium line has driven Greater China Baby Care double-digit organic sales growth over the past eighteen months, and increased share nearly three points." > — Shailesh Jejurikar, Investor Focus · Q2 FY2026 ## MoonshotScore Pillars | Pillar | Score | Level | Evidence | |---|---|---|---| | Revenue Growth | 1.0 | weak | Q3 vs Q4: growth slowing (+1.7%, below threshold) | | Gross Margin | 5.0 | medium | Q3: average margin (49.5%) | | Operating Leverage | 2.0 | weak | op margin healthy (21.5%) | | Cash Runway | 10.0 | strong | FCF very strong ($3.0B, 3.0× CapEx) | | R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) | | Price Momentum | 4.0 | medium | RSI 52.1 balanced, 50d below | | News Sentiment | 6.0 | medium | majority buy (58%) | **Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula. ## Council (7-Lens) | Name | Stance | Context | |---|---|---| | Ray Dalio | bull | macro · target upside +11.0% | | Ken Griffin | bear | flow · 50d MA below | | Jim Simons | neutral | quant · RSI 52 | | Klarman | neutral | value · target upside +11.0% | | Buffett | bull | quality · ROE score 5/5 | | Munger | neutral | valuation · target upside +11.0% | **Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr. ## Munger Lens - **Verdict:** Fairly Valued - **Financial Health:** Moderate - **Margin of Safety:** Moderate - **Interest Coverage:** Adequate - **ROIC vs WACC:** Healthy **Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget. ## Technical Levels - **RSI(14):** 52.1 — dengeli — yön sinyali zayıf - **50d MA:** $150 — hisse %1.5 altında — kısa vadeli direnç - **200d MA:** $151 — hisse %2.3 altında — uzun vadeli baskı - **Volume (10d):** -28% ## Past Performance (4 Quarters) | Quarter | EPS Actual | EPS Estimate | Result | Reaction | |---|---|---|---|---| | Q4 FY25 | $1.48 | $1.42 | BEAT | -2.4% | | Q1 FY26 | $1.99 | $1.90 | BEAT | -0.5% | | Q2 FY26 | $1.88 | $1.86 | BEAT | +0.1% | | Q3 FY26 | $1.59 | $1.56 | +1.9% EPS | +0.1% | Q2 (January 22, 2026): EPS $1.59 vs $1.56 est^[FMP], +1.9% beat. D+1 movement: +0.1%^{[FMP D+1]}. Decline despite beat — market reacted to guidance, not numbers. ## 3 Scenarios ### Scenario A · Beat **Q1 EPS > $1.46 + CapEx discipline** Threshold: EPS > $1.46^{[FMP est]}. Target: Break above median target $164^{[FMP target]}; high target $179^[FMP] upper bound. ### Scenario B · In-Line **EPS ≈ $1.46 + CapEx < $1.0B** Threshold: EPS ≈ $1.46^{[FMP est]}, Q1 CapEx < $1.0B^[FMP]. Target: Consolidation in the band between current $147^[FMP] and median $164^[FMP]. ### Scenario C · Miss **EPS < $1.42 or CapEx ≥ $1.0B** Threshold: EPS < $1.42^{[FMP est×0.97]}. Target: Current $147 below SMA200 $151^[FMP], if rejection continues, $128^[derived] support activates. ## Risk Notes ### Primary segment below threshold Q2: EPS $1.59 vs $1.56 beat^[FMP], stock +0.1% D+1^[FMP]. ### Backlog concentration No RPO/backlog concentration disclosed in Q2 earnings call. ### Insider trading Form 4 data is marked in the table — this page does not generate assumptions for this stock. | Executive | Action | Amount | Date | |---|---|---|---| **Net:** — (0 transactions · 0 sells · 0 buys) · Q3 FY26 ### CapEx shock Q2 CapEx $1.0B^{[FMP cashflow]}. Q2 op margin 21.5%^{[FMP op margin]} — this level in Q1 is sensitive to CapEx revision risk. ## Wall Street Consensus - **Median target:** $164 (+11.0% upside vs current $147) - **High / Low:** $179 / $142 - **Buy / Hold / Sell:** 14 / 10 / 0 - **Analyst count:** 8 (last quarter), 77 all-time ## Additional Transcript Insights ### 1. organic_sales_growth_confidence **Claim:** PG is confident that the interventions and investments they are making now will improve near-term performance. **Evidence (transcript):** "We are confident the interventions and investments we are making now will improve our near-term performance." **Numbers:** — ### 2. china_baby_care_growth **Claim:** China Baby Care is leading growth of the premium and super-premium segments of the market behind consumer insight-driven innovation, and brand communication. **Evidence (transcript):** "Greater China Baby Care was one of the first categories to make step change and continues to lead growth of the premium and super-premium segments of the market behind consumer insight-driven innovation, and brand communication." **Numbers:** — ### 3. pampers_prestige_success **Claim:** Pampers Prestige has driven double-digit organic sales growth and increased share nearly three points in Greater China with its silky ingredients and luxurious packaging. **Evidence (transcript):** "Reframing our superior premium line has driven Greater China Baby Care double-digit organic sales growth over the past eighteen months, and increased share nearly three points." **Numbers:** double-digit, three ### 4. downy_intense_perfume_innovation **Claim:** Downy Intense leverages perfume innovation and consumer insight, driving double-digit organic sales growth and over two points for value share growth in the Mexico fabric enhancer category. **Evidence (transcript):** "These deep consumer insights driving innovation and executed with shopper brand communication and retail execution as spurred Mexico fabric enhancer category growth, and led Downey to double-digit organic sales growth and over two points for value share growth." **Numbers:** double-digit, two ### 5. fy26_guidance_maintained **Claim:** PG is maintaining fiscal year 2026 guidance ranges across organic sales, core EPS, and adjusted free cash flow productivity, despite softer consumer markets and competition. **Evidence (transcript):** "We expect stronger results in the second half which enables us to maintain fiscal year 2026 guidance ranges across organic sales core EPS and adjusted free cash flow productivity." **Numbers:** 2026 ### 6. fy26_organic_sales_guidance **Claim:** PG continues to expect organic sales growth of in line to plus 4% for fiscal year 2026, which includes 30 to 50 basis points of headwind from product and market exits. **Evidence (transcript):** "For fiscal 'twenty-six, we continue to expect organic sales growth of in line to plus 4%. As a reminder, this guidance includes 30 to 50 basis points of headwind from product and market exits, that are part of our restructuring work." **Numbers:** 4%, 30, 50 --- *Data source: FMP (live query, 2026-05-03), Q2 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*